AC
DGX icon

Arjuna Capital’s Quest Diagnostics DGX Stock Holding History

Arjuna Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Sell
8,298
-31
-0.4% -$6.08K 0.4% 64
2026
Q1 		$1.63M Sell
8,329
-1,134
-12% -$220K 0.42% 61
2025
Q4 		$1.64M Buy
9,463
+328
+4% +$59.7K 0.4% 62
2025
Q3 		$1.74M Buy
9,135
+491
+6% +$87.1K 0.43% 54
2025
Q2 		$1.55M Sell
8,644
-687
-7% -$119K 0.41% 56
2025
Q1 		$1.58M Sell
9,331
-783
-8% -$129K 0.44% 55
2024
Q4 		$1.53M Sell
10,114
-14,800
-59% -$2.3M 0.41% 63
2024
Q3 		$3.87M Buy
24,914
+23,128
+1,295% +$3.45M 1% 31
2024
Q2 		$244K Buy
1,786
+16
+0.9% +$2.19K 0.07% 95
2024
Q1 		$236K Buy
1,770
+88
+5% +$11.4K 0.07% 95
2023
Q4 		$232K Sell
1,682
-11,381
-87% -$1.5M 0.07% 87
2023
Q3 		$1.59M Buy
13,063
+478
+4% +$63.7K 0.57% 53
2023
Q2 		$1.77M Buy
12,585
+645
+5% +$88.9K 0.63% 47
2023
Q1 		$1.69M Buy
11,940
+9,337
+359% +$1.34M 0.66% 45
2022
Q4 		$407K Buy
2,603
+95
+4% +$13.7K 0.19% 78
2022
Q3 		$308K Buy
+2,508
New +$330K 0.15% 83

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Arjuna Capital's DGX Position: Q2 2026 in Review

Arjuna Capital reduced its Quest Diagnostics (DGX) stake by 0.37% in Q2 2026, selling an estimated $6.08K and leaving 8,298 shares worth $1.76M. The position accounts for 0.4% of the portfolio, ranked #64.

Arjuna Capital first reported a position in DGX in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.87M in Q3 2024. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Arjuna Capital held 8,298 shares of Quest Diagnostics worth $1.76M as of Q2 2026.
  • Arjuna Capital sold 31 Quest Diagnostics shares in Q2 2026, an estimated $6.08K.
  • Quest Diagnostics made up 0.4% of Arjuna Capital's portfolio in Q2 2026, its #64 holding.
  • Arjuna Capital first reported a position in Quest Diagnostics in Q3 2022 and has held it in 16 quarters since.
  • Arjuna Capital's Quest Diagnostics position peaked at $3.87M in Q3 2024.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Arjuna Capital's 13F filing for Q2 2026, filed 14 Aug 2026.